Visceral leishmaniasis is responsible for up to 30,000 deaths every year. Current treatments
have shortcomings that include toxicity and variable efficacy across endemic regions …

Visceral leishmaniasis (VL), a fatal disease prevalent in more than 70 countries, poses
significant health challenges, particularly in poor communities with limited access to …

In silico prediction of antileishmanial activity using quantitative structure–activity relationship
(QSAR) models has been developed on limited and small datasets. Nowadays, the …

Abstract Clioquinol (5-chloro-7-iodoquinolin-8-ol or ICHQ) was recently showed to presents
an in vitro effective antileishmanial action, causing changes in membrane permeability …

Background Focused efforts of the visceral leishmaniasis elimination program have led to a
drastic decline in cases, and the present challenge is disease monitoring, which this study …

To the Editor: An 18-mo-old toddler hailing from Nepal presented to us with persistent fever
of 4 mo duration, anemia and splenohepatomegaly. Laboratory studies demonstrated …

This chapter provides a concise overview of adverse effects/events caused by drugs used as
anti-protozoal medications including drugs used for malaria, leishmaniasis, toxoplasmosis …

The American Society for Tropical Medicine and Hygiene recently inaugurated an award for
the best clinical research article published in the society's journal in the previous year. This …

The American Society for Tropical Medicine and Hygiene recently inaugurated an award for
the best clinical research article published in the society's journal in the previous year. This …

Efficacy and safety of treatment for Old World cutaneous leishmaniasis in pediatric patients: a
case series Page 1 Correspondence Clinical Letter 1067 © 2021 The Authors. Journal der …